Strategies to Overcome High-Risk Multiple Myeloma

被引：1

作者：

Sanchez, Larysa ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Multiple Myeloma Program, New York, NY 10029 USA

来源：

CANCER JOURNAL | 2021年 / 27卷 / 03期

关键词：

High risk; high-risk myeloma; myeloma; multiple myeloma; DARATUMUMAB PLUS LENALIDOMIDE; STEM-CELL TRANSPLANTATION; OPEN-LABEL; CONSOLIDATION THERAPY; DEXAMETHASONE; BORTEZOMIB; SURVIVAL; CARFILZOMIB; PREDNISONE; MELPHALAN;

D O I：

10.1097/PPO.0000000000000529

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multiple myeloma (MM) patients with high-risk cytogenetics continue to have inferior outcomes despite recent advances in the treatment of MM. As defined by the International Myeloma Working Group, the presence of t(4;14), t(14;16), del(17p), t(14;20) and amplification of 1q are considered to be high-risk chromosomal abnormalities associated with poor survival. Despite the use of immunomodulatory agents, proteasome inhibitors, autologous stem cell transplantation, and anti-CD38 monoclonal antibodies, clinical trials of current therapies have not shown strong statistical evidence of being able to overcome the poor prognosis of high-risk disease. Novel treatment approaches are urgently needed to improve survival in this subset of MM patients.

引用

页码：201 / 204

页数：4

共 50 条

[41] Healthcare reality of the treatment of the high-risk multiple myeloma in Spain [J].

Hernandez-Rivas, Jose-Angel ;

Gironella Mesa, Mercedes .

MEDICINA CLINICA, 2020, 154 (08) :315-319

[42] Treatment options for multiple myeloma patients with high-risk disease [J].

Sikander Ailawadhi ;

Aisha Masood ;

Taimur Sher ;

Kena C. Miller ;

Margaret Wood ;

Kelvin Lee ;

Asher Chanan-Khan .

Medical Oncology, 2010, 27 :53-61

[43] High-Risk Multiple Myeloma: Different Definitions, Different Outcomes? [J].

Paszekova, Helena ;

Kryukov, Fedor ;

Kubiczkova, Lenka ;

Hajek, Roman ;

Sevcikova, Sabina .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01) :24-30

[44] Daratumumab for the treatment of multiple myeloma [J].

Goldsmith, S. R. ;

Foley, N. ;

Schroeder, M. A. .

DRUGS OF TODAY, 2021, 57 (10) :591-605

[45] Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115 [J].

Sanchorawala, V. ;

Hoering, A. ;

Seldin, D. C. ;

Finn, K. T. ;

Fennessey, S. A. ;

Sexton, R. ;

Mattar, B. ;

Safah, H. F. ;

Holmberg, L. A. ;

Dean, R. M. ;

Orlowski, R. Z. ;

Barlogie, B. .

BONE MARROW TRANSPLANTATION, 2013, 48 (12) :1537-1542

[46] Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21 [J].

Nahi, Hareth ;

Vatsveen, Thea Kristin ;

Lund, Johan ;

Heeg, Bart M. S. ;

Preiss, Birgitte ;

Alici, Evren ;

Moller, Michael Boe ;

Wader, Karin Fahl ;

Moller, Hanne E. H. ;

Groseth, Lill Anny ;

Ostergaard, Brian ;

Dai, Hong Yan ;

Holmberg, Erik ;

Gahrton, Gosta ;

Waage, Anders ;

Abildgaard, Niels .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) :46-54

[47] A rational approach to functional high-risk myeloma [J].

Gay, Francesca ;

Bertuglia, Giuseppe ;

Mina, Roberto .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) :433-442

[48] Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation [J].

Alsina, Melissa ;

Becker, Pamela S. ;

Zhong, Xiaobo ;

Adams, Alexia ;

Hari, Parameswaran ;

Rowley, Scott ;

Stadtmauer, Edward A. ;

Vesole, David H. ;

Logan, Brent ;

Weisdorf, Daniel ;

Qazilbash, Muzaffar ;

Popplewell, Leslie L. ;

McClune, Brian ;

Bensinger, William ;

Riches, Marcie ;

Giralt, Sergio A. ;

Pasquini, Marcelo C. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) :1183-1189

[49] Variability of definition of high-risk multiple myeloma across phase III clinical trials [J].

Abu Za'nouneh, Faris Jamal ;

Ababneh, Obada ;

Schinke, Carolina ;

Thanendrarajan, Sharmilan ;

Zangari, Maurizio ;

Shaughnessy Jr, John D. ;

Zhan, Fenghuang ;

van Rhee, Frits ;

Al Hadidi, Samer .

EJHAEM, 2023, 4 (02) :454-458

[50] Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients [J].

Gardeney, Helene ;

Bobin, Arthur ;

Gruchet, Cecile ;

Sabirou, Florence ;

Levy, Anthony ;

Nsiala, Laly ;

Cailly, Laura ;

Tomowiak, Cecile ;

Torregrosa, Jose ;

Moya, Niels ;

Hulin, Cyrille ;

Leleu, Xavier ;

Guidez, Stephanie .

JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11)

← 1 2 3 4 5 →